More about
Adalimumab
News
January 17, 2023
13 min read
Save
Humira exclusivity expires in 2023: Will biosimilar boom benefit patients or industry?
News
January 11, 2023
2 min read
Save
Etanercept, adalimumab improve wellbeing in non-systemic juvenile idiopathic arthritis
News
December 23, 2022
1 min read
Save
Top in rheumatology: Adalimumab biosimilar approval; the immunopathophysiology of PsA
News
December 20, 2022
14 min read
Save
Hoping for a biosimilar ‘sea change’: Rheumatologists weigh 2023 end of Humira exclusivity
News
December 15, 2022
2 min read
Save
Cigna Pharmacy to list adalimumab biosimilars at same price point as originator
News
December 14, 2022
1 min read
Save
FDA approves Fresenius Kabi’s Idacio as eighth adalimumab biosimilar
News
November 30, 2022
2 min read
Save
Switching from adalimumab to upadacitinib demonstrates clinical improvement for patients with RA
News
November 29, 2022
2 min read
Save
Upadacitinib effective in patients with RA who failed prior TNF inhibitor therapy
News
November 28, 2022
2 min read
Save
Upadacitinib shows greater improvement in PsA compared with adalimumab, placebo
News
October 21, 2022
1 min read
Save